Close

Rating History for Bristol-Myers Squibb Co. (BMY) by Morgan Stanley

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/2/2022 Matthew Harrison Maintain Underweight
(N/A)
63.00
(64.00)
 
 
  Details